Frances Boyle
Clinical Oncology Society of Australia Annual Scientific Meeting 2026
Days
Wednesday, 11th November
Thursday, 12th November
Friday, 13th November
Search
Speakers
Frances Boyle
Abstracts this author is presenting:
monarchE: Primary overall survival (OS) results of adjuvant abemaciclib + endocrine therapy (ET) for HR+, HER2-, high-risk early breast cancer (EBC)
—
Thursday Poster Session
monarchE: Subgroup analysis of adjuvant abemaciclib + endocrine therapy (ET) for HR+, HER2-, high-risk early breast cancer (EBC) by nodal status
—
Thursday Poster Session
Treatment experiences, preferences, and information needs among Australians living with metastatic breast cancer: results from a national survey
—
Wednesday Poster Session